AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment

Recruitingn/aAges 18 Years - anyMaleFundación Instituto Valenciano de Oncología
💬

In plain words

What the trial is, and whether it could suit you

Stress urinary incontinence is a significant potential source of morbidity after radical prostatectomy or radiation therapy for prostate cancer. At present, artificial urinary sphincter remains the preferred therapeutic option. However, this technique is not free from complications. In an attempt to avoid such complications, male sling has been suggested for use in patients with mild degrees of stress incontinence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. The subject has agreed to be treated with the male Incontinence surgery devices 2. The subject is willing and able to give valid informed consent. 3. The subject is \> 18 years of age. 4. The subject has confirmed stress urinary incontinence for at least 12 months after prostatectomy or radiotherapy. 5. It has been confirmed the stress urinary incontinence with 24-Hour Pad Weight test 6. Pre-operative urodynamic assessment and flexible cystoscopy were performed in all cases 7. The subject is willing and able to return for follow-up evaluations and questionnaire completion according to the study protocol. 8. There are no surgical contraindications. Exclusion Criteria: 1. The subject has an active urinary tract infection or active skin infection in region of surgery 2. The subject has serious bleeding disorders 3. The subject has unstable bladder neck stricture disease 4. The subject has Neurogenic bladder condition that is not treatable or controllable by pharmacological or alternative methods. 5. The subject has Detrusor-external sphincter dyssynergia. 6. The subject is unable or unwilling to sign the informed consent form (ICF)and/or comply with all follow-up requirements according to the study protocol 7. The subject is likely to undergo radiation therapy within the next 6 months 8. The subject has a history of connective tissue or autoimmune conditions. 9. The subject has a compromised immune system. 10. The subject has renal insufficiency, and upper and/or lower urinary tract relative obstruction. 11. The subject's reading level is judged inadequate for reading and understanding the quality of life questionnaires and other study materials
💊

What it tests

  • AMS-800
  • ADVANCE/ADVANCEXP
  • VIRTUE
  • INVANCE
📍

Where

1 site
Argimiro Collado
Valencia, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy